I guess I'm taking the adage that you shouldn't invest in something that you're not familiar with... that being said, our first CGM has been the G4. Our endocrinologist at CHOP tried to talk us out of it, trying to get us on the minimed... anway, the G4 is a life changer. My daughter came down with T1 and before that, in order to maintain tight control, we were pricking her fingers something like 16x a day (she's been honeymooning for close to 2 years now.. using about 1/2 the insulin per Kg of weight).. The G4 is, hands down, the greatest thing I've purchased.. so.. with that, I want to sink in a good chunk of my investing money into DXCM.. However, I 've noticed that a lot of people (doctors) are like "huh ? what is that" when we show them our daughters CGM.. some of the other T1's in her school are on the pump and didn't know anything about the DEX, and yet, we find that a CGM has more to do with better A1C's than what the pump would offer us (ie. we can have her hang in the 70's and 80's at night, and know the DEX will warn us if there's an issue).. basically, I'm a little afraid to invest in DEX, since it seems like many in the profession (pediatricians) and even our endo are like #$%$" is that ? comments ?
You're right about not investing into something if you're not familiar with it.
There is another side of it - technology is not the same as company and company is not the same as trading symbol on exchange.
Technology maybe great but company's management may have their own illusions and delusions. Management may be great too but Wall Street expectations are too high and earning report that looks perfectly ok would cause the share price tank.
My point is - don't invest into DXCM just because you like G4. How do you know if 15.50 is a good entry point? And if you get in what would be your exit price and what would be your stop loss price ?
I think it's perfectly fine to get emotional with technology especially if it relates to your loved ones but don't you ever get emotional with stock ticker. You don't really helping company by investing into its shares - you're just making some broker/marketmaker/trader richer.
That's a fair post.. however, being a techy I kind of appreciate what they're doing. I used to work for a telecom company, and when the CEO/Engineer ran the place, the stock was 'ok', but we were an engineering company and made good stuff, but these guys weren't showmen. Then came the wall street crew, and they brought in a guy from Motorola who proceeded to drive the company into the ground... gutting engineering and putting everything into sales. Short term, that's great..but in the end, it's the product.. but I agree, sometimes the product isn't good enough (just look at the success of Oracle and the antithesis of a good product ). As an investor, I'm skeptical about buying into this company only because it looks like a one trick pony..but the counterpoint is, there are only two ponies.
These are some excerpts from a 3-28-13 article from the diaTribe website.
In February, Dexcom submitted an application to expand the label for the G4 Platinum CGM (continuous glucose monitor) to pediatric patients who are as young as two years old. The FDA normally responds to these applications after 180 days, and we expect a decision from the agency during the second half of 2013. Currently, the G4 is only approved for those who are 18 years and older. Though some children are now using the CGM, they are using it “off-label,” and not all healthcare providers (HCPs) are comfortable prescribing therapies in this way.
Dexcom is also working on a new remote monitoring product, Dexcom Share. The product is a cradle that holds the G4 Platinum receiver and plugs into a power outlet at a user’s bedside. Data from the G4 Platinum are then sent via the cradle (using Bluetooth) to a nearby smartphone. That phone then uploads the data to a web-based platform, where it can be monitored by parents or caregivers on their own cellphones. At the ATTD conference, Dexcom showed a picture of a father on a business trip in a taxi, checking his phone with a sigh of relief that his daughter’s CGM reading was 150 mg/dl.